At a stormy annual general meeting held yesterday, chairman K Ravikumar found himself on the defensive, while the employee-shareholder combine aggressively questioned the management on the poor performance of the company.
Angry shareholders wanted an explanation from the chairman on the fall in scrip price.
The Arochem issue figured prominently at the meeting.